As of the latest Form 4 filed Jul 1, 2026.
What Cadrenal Therapeutics, Inc. Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 22 most recent filings for CVKD.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-01 | 2026-06-29 | Pham Quang X Chairman and CEO | SSale | −7.40K | $3.03 | $22.4K | Yes (planned) | Form 4 ↗ |
| 2026-06-26 | 2026-06-26 | Pham Quang X Chairman, CEO and Interim CFO | SSale | −9.03K | $3.05 | $27.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-26 | 2026-06-25 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −2.13K | $3.00 | $6.38K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-23 | Pham Quang X Chairman, CEO and Interim CFO | SSale | −2.28K | $3.20 | $7.29K | Yes (planned) | Form 4 ↗ |
| 2026-06-24 | 2026-06-22 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −9.17K | $3.55 | $32.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-17 | Pham Quang X Chairman, CEO and Interim CFO | SSale | −513.00 | $3.16 | $1.62K | Yes (planned) | Form 4 ↗ |
| 2026-06-18 | 2026-06-16 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −3.61K | $3.18 | $11.5K | Yes (planned) | Form 4 ↗ |
| 2026-06-15 | 2026-06-15 | Pham Quang X Chairman, CEO and Interim CFO | SSale | −3.67K | $3.58 | $13.1K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-12 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −13.0K | $3.94 | $51.2K | No | Form 4 ↗ |
| 2026-06-15 | 2026-06-11 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −1.46K | $4.12 | $6.02K | No | Form 4 ↗ |
| 2026-06-10 | 2026-06-10 | Pham Quang X Chairman, CEO and Interim CFO | SSale | −3.50K | $4.21 | $14.7K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-09 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −13.0K | $4.06 | $52.7K | Yes (planned) | Form 4 ↗ |
| 2026-06-10 | 2026-06-08 | Pham Quang X, Chairman, CEO and Interim CFO | SSale | −5.89K | $4.38 | $25.8K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-05 | Pham Quang X CEO and Chairman | SSale | −2.06K | $4.42 | $9.12K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-04 | Pham Quang X, CEO and Chairman | SSale | −3.90K | $4.41 | $17.2K | Yes (planned) | Form 4 ↗ |
| 2026-06-05 | 2026-06-03 | Pham Quang X, CEO and Chairman | SSale | −2.32K | $4.26 | $9.90K | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-06-02 | Pham Quang X CEO and Chairman | SSale | −349.00 | $4.46 | $1.56K | Yes (planned) | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | Pham Quang X, CEO and Chairman | SSale | −303.00 | $5.01 | $1.52K | Yes (planned) | Form 4 ↗ |
| 2026-05-29 | 2026-05-28 | Pham Quang X CEO and Chairman | SSale | −2.99K | $4.93 | $14.7K | Yes (planned) | Form 4 ↗ |
| 2026-05-29 | 2026-05-12 | Pham Quang X, CEO and Chairman | SSale | −3.30K | $5.28 | $17.4K | Yes (planned) | Form 4 ↗ |
| 2026-05-29 | 2026-05-11 | Pham Quang X, CEO and Chairman | SSale | −6.48K | $5.76 | $37.3K | Yes (planned) | Form 4 ↗ |
| 2026-05-26 | 2026-05-22 | Pham Quang X CEO and Chairman | SSale | −1.17K | $5.69 | $6.63K | Yes (planned) | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CVKD’s full analysis or the market-wide insider trading feed. The tabs above jump to CVKD’s other SEC data.
Source: SEC Form 4 filings for CVKD, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.